VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PHRPhreesia, Inc.
$10.07$622M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPHRBalance Sheet

Phreesia, Inc. (PHR) Balance Sheet

9Y historyFree accessUpdated daily

The company maintains a conservative financial profile with a debt-to-equity ratio of 0.26, though total assets are increasingly comprised of $169.5 million in goodwill.

PHR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Jan'25Jan'24Jan'23Jan'22Jan'21Jan'20Jan'19Jan'18
Total Current Assets267.26M279.84M203.28M195.68M262.44M386.35M272.27M131.54M32.88M35.95M
Cash & Short-Term Investments74.71M73.83M84.22M87.52M176.68M313.81M218.78M90.31M1.54M10.5M
Cash Only74.71M73.83M84.22M87.52M176.68M313.81M218.78M90.31M1.54M10.5M
Short-Term Investments0000000000
Accounts Receivable143.31M154.63M73.62M64.86M51.39M40.26M29.05M21.98M26.29M12.31M
Days Sales Outstanding85.25117.4464.0166.4566.7868.9271.3264.2996.0756.28
Inventory000768K1.06M1.64M8.95M6.88M1.67M1.64M
Days Inventory Outstanding---2.263.537.3662.3456.1316.520.1
Other Current Assets49.25M51.39M34.13M32.48M25.94M21.74M15.49M13.26M1.67M8.68M
Total Non-Current Assets398.88M383.95M185.13M174.64M107.62M108.13M54.4M27.22M26.38M21.18M
Property, Plant & Equipment23.4M23.59M25.13M17.17M22.24M36.98M29.31M14.49M14.21M13.17M
Fixed Asset Turnover21.00x20.37x16.71x20.75x12.63x5.77x5.07x8.61x7.03x6.06x
Goodwill169.51M170.06M75.84M75.84M33.74M33.62M8.31M250K250.19K0
Intangible Assets77.15M79.76M80.91M77.76M46.55M30.41M13.2M9.93M9.25M6.72M
Long-Term Investments66.15M00002.44M1.25M1.59M081.87K
Other Non-Current Assets61.08M108.94M3.25M3.87M5.01M4.16M1.67M180K2.67M1.3M
Total Assets666.14M663.79M388.42M370.33M370.06M494.48M326.67M158.76M59.26M57.14M
Asset Turnover0.92x0.72x1.08x0.96x0.76x0.43x0.46x0.79x1.69x1.40x
Asset Growth %162.79%70.9%4.88%0.07%-25.16%51.37%105.76%167.89%3.72%-
Total Current Liabilities152.11M183.24M114.02M110.12M79.04M68.43M54.99M35.35M27.93M24.98M
Accounts Payable11.89M11.48M5.62M8.48M10.84M5.12M4.39M6.02M3.75M2.2M
Days Payables Outstanding19.4527.1815.2124.9636.222.9630.5849.113727
Short-Term Debt6.36M2.66M1.22M1.1M246K221K4.86M2.32M97K1.17M
Deferred Revenue (Current)145.71M49.52M32.76M24.11M17.69M16.49M10.84M5.4M6.49M4.89M
Other Current Liabilities94.29M72.29M844K53.16M32.57M26.84M24.87M16.58M10.22M8.68M
Current Ratio1.76x1.53x1.78x1.78x3.32x5.65x4.95x3.72x1.18x1.44x
Quick Ratio1.76x1.53x1.78x1.77x3.31x5.62x4.79x3.53x1.12x1.37x
Cash Conversion Cycle65.81--43.7534.1153.32103.0871.3175.5749.37
Total Non-Current Liabilities154.94M143.34M9.58M8.76M3.2M8.76M8.37M21.54M242.31M199.84M
Long-Term Debt85.3M90M719K2.05M2.73M139K6.47M21.54M27.92M19.45M
Capital Lease Obligations4.93M3.22M8.08M3.48M3.07M8.56M1.9M2.1M2.4M652.41K
Deferred Tax Liabilities10.43M4.5M484K270K000000
Other Non-Current Liabilities64.12M45.62M185K2.86M-2.73M00-2.1M211.99M179.73M
Total Liabilities307.05M326.58M123.61M118.88M82.24M77.2M63.36M56.89M270.24M224.82M
Total Debt92.56M102.45M17.8M11.98M9.18M15.8M14.32M23.86M32.29M22.93M
Net Debt17.85M28.62M-66.42M-75.54M-167.5M-298.01M-204.46M-66.45M30.74M12.43M
Debt / Equity0.26x0.30x0.07x0.05x0.03x0.04x0.05x0.23x--
Debt / EBITDA2.42x4.12x------15.37x-
Net Debt / EBITDA0.47x1.15x------14.64x-
Interest Coverage0.83x-0.29x-22.78x-72.00x-123.50x-100.44x-15.07x-6.25x-2.71x-4.00x
Total Equity359.09M337.21M264.81M251.45M287.82M417.28M263.31M101.86M-210.97M-167.68M
Equity Growth %98.98%27.34%5.31%-12.64%-31.03%58.48%158.49%148.28%-25.82%-
Book Value per Share5.795.484.604.615.498.366.665.02-114.35-108.98
Total Shareholders' Equity359.09M337.21M264.81M251.45M287.82M417.28M263.31M101.86M-210.97M-167.68M
Common Stock632K620K601K577K542K521K449K366K19.95K16.38K
Retained Earnings-796.23M-799.19M-801.5M-742.97M-606.08M-429.94M-311.78M-284.49M-210.99M-167.7M
Treasury Stock-46.62M-45.52M-45.52M-45.52M-33.6M-13.96M-4.96M-399K00
Accumulated OCI-571K-382K-51K0000-158.76M-27.86M-20.33M
Minority Interest0000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

EHR platform native competition

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Asset Expansion Outpacing Equity Growth

According to recent financial filings, Phreesia's total assets grew from $371.1 million in 2024Q4 to $666.1 million by 2027Q1, a trend that appears to be driven by aggressive acquisition activity rather than organic accumulation of high-quality, liquid capital reserves on the balance sheet.

The rapid expansion of the asset base, particularly the jump in goodwill, suggests that the company is prioritizing inorganic growth to maintain its market position. Investors should monitor whether these acquired assets generate sufficient returns to justify the dilution of equity and the increased complexity of the balance sheet.

Leverage Remains Modest Despite Growth

As reported in quarterly statements, Phreesia maintains a conservative debt-to-equity ratio of 0.26 as of 2027Q1, indicating that the company has largely avoided reliance on external debt financing to fund its ongoing operational scaling and recent strategic acquisition initiatives.

The low leverage profile provides the company with significant financial flexibility, which may be critical as it navigates competitive pressures from integrated EHR providers. However, the recent increase in debt levels warrants investigation to ensure that future interest obligations do not constrain the company's path to sustained GAAP profitability.

Goodwill Concentration Risks Asset Quality

Based on the provided balance sheet data, goodwill has surged from $75.8 million in 2024Q4 to $169.5 million in 2027Q1, representing a significant portion of total assets that may be vulnerable to impairment if acquired business units fail to meet performance expectations.

The heavy reliance on intangible assets suggests that the company's value is increasingly tied to the successful integration of its acquisitions rather than tangible infrastructure. This shift necessitates a cautious approach, as any shortfall in the performance of these acquired entities could lead to non-cash charges that would negatively impact the company's equity position.

Liquidity Buffer Remains Sufficiently Stable

As indicated by the latest financial disclosures, Phreesia's current ratio of 1.76 in 2027Q1 reflects a stable liquidity position, providing a reasonable buffer against short-term operational shocks despite the company's ongoing transition toward achieving consistent, self-sustaining cash flow from its core business operations.

The current ratio suggests that the company is well-positioned to meet its near-term obligations without immediate recourse to external capital markets. Nevertheless, the cash position relative to total liabilities suggests that management must maintain strict discipline over working capital to ensure that liquidity remains adequate during periods of high investment.

PHR — Frequently Asked Questions

Quick answers to the most common questions about buying PHR stock.

What are the total assets of Phreesia, Inc. (PHR)?

As of 2026, Phreesia, Inc. (PHR) had total assets of $663.8M including $279.8M in current assets.

How much debt does Phreesia, Inc. (PHR) have?

Phreesia, Inc. (PHR) carries total debt of $102.4M, offset by $73.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Phreesia, Inc.?

Phreesia, Inc. (PHR) has total shareholders' equity (book value) of $337.2M ($5.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Phreesia, Inc.'s current ratio and liquidity?

Phreesia, Inc. (PHR) reported a current ratio of 1.53x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.